Established, emerging and future applications of FDG-PET/CT in the uterine cancer

K. Kitajima, K. Murakami, Y. Kaji, S. Sakamoto, K. Sugimura

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.

Original languageEnglish
Pages (from-to)297-307
Number of pages11
JournalClinical Radiology
Volume66
Issue number4
DOIs
Publication statusPublished - 2011 Apr

Fingerprint

Uterine Neoplasms
Glucose
Endometrial Neoplasms
Uterine Cervical Neoplasms
Equipment and Supplies
Positron Emission Tomography Computed Tomography
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Kitajima, K., Murakami, K., Kaji, Y., Sakamoto, S., & Sugimura, K. (2011). Established, emerging and future applications of FDG-PET/CT in the uterine cancer. Clinical Radiology, 66(4), 297-307. https://doi.org/10.1016/j.crad.2010.07.012

Established, emerging and future applications of FDG-PET/CT in the uterine cancer. / Kitajima, K.; Murakami, K.; Kaji, Y.; Sakamoto, S.; Sugimura, K.

In: Clinical Radiology, Vol. 66, No. 4, 04.2011, p. 297-307.

Research output: Contribution to journalArticle

Kitajima, K, Murakami, K, Kaji, Y, Sakamoto, S & Sugimura, K 2011, 'Established, emerging and future applications of FDG-PET/CT in the uterine cancer', Clinical Radiology, vol. 66, no. 4, pp. 297-307. https://doi.org/10.1016/j.crad.2010.07.012
Kitajima, K. ; Murakami, K. ; Kaji, Y. ; Sakamoto, S. ; Sugimura, K. / Established, emerging and future applications of FDG-PET/CT in the uterine cancer. In: Clinical Radiology. 2011 ; Vol. 66, No. 4. pp. 297-307.
@article{a447790713904846a9c182a66998ac58,
title = "Established, emerging and future applications of FDG-PET/CT in the uterine cancer",
abstract = "Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.",
author = "K. Kitajima and K. Murakami and Y. Kaji and S. Sakamoto and K. Sugimura",
year = "2011",
month = "4",
doi = "10.1016/j.crad.2010.07.012",
language = "English",
volume = "66",
pages = "297--307",
journal = "Clinical Radiology",
issn = "0009-9260",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Established, emerging and future applications of FDG-PET/CT in the uterine cancer

AU - Kitajima, K.

AU - Murakami, K.

AU - Kaji, Y.

AU - Sakamoto, S.

AU - Sugimura, K.

PY - 2011/4

Y1 - 2011/4

N2 - Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.

AB - Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.

UR - http://www.scopus.com/inward/record.url?scp=79952313806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952313806&partnerID=8YFLogxK

U2 - 10.1016/j.crad.2010.07.012

DO - 10.1016/j.crad.2010.07.012

M3 - Article

C2 - 21356392

AN - SCOPUS:79952313806

VL - 66

SP - 297

EP - 307

JO - Clinical Radiology

JF - Clinical Radiology

SN - 0009-9260

IS - 4

ER -